This gene helps your body control how strongly a growth signal called insulin-like growth factor 2 acts in tissues. The IGFBP6 gene makes a protein that binds this signal and helps keep cell growth, survival, and tissue repair in balance. If the gene does not work as expected, growth control may become less steady, which may play a role in some cancers and other tissue changes.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or guide processes in the body. Some genes carry the information needed to produce proteins, the working parts of cells. Other genes mainly regulate when certain processes happen, where they take place, and how strongly they run. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. If you want to go into this subject in more detail, you can read more in the LearnHub.
Overview
IGFBP6Gene function
What if the gene works
The IGFBP6 gene makes a protein that binds insulin-like growth factor 2, a signal that influences growth. By holding onto this signal, it helps control cell growth, movement, and development.
Risk
What if the gene does not work
Milder to more severe variants in the IGFBP6 gene can weaken how its protein holds onto IGF2, a growth signal, leaving more of that signal active around cells. This may change growth signaling and cell movement.
Treatment
What does that mean for your treatment
No IGFBP6-specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the IGFBP6 gene. The IGFBP6 gene is being studied as a possible cancer biomarker and drug target, but this has not changed routine care.
Gene function
What if the gene works
Growth signals need careful timing, not just the right amount. The IGFBP6 gene makes a protein that mainly binds a growth messenger called IGF2 and helps control when that message reaches cells. This is a key part of what the IGFBP6 gene does in the body during development and everyday tissue upkeep.
The IGFBP6 gene makes a protein that strongly attaches to IGF2, a growth signal used by many tissues. By holding IGF2 in the spaces around cells, it helps control how much of that signal is free to act.
This protein helps fine tune growth messages so cells respond in a measured way. That steady pacing supports normal development, tissue renewal, and cell maturation.
IGFBP6 can carry IGF2 through body fluids and the spaces between cells. This helps keep the signal stable long enough to reach the right tissues at the right time.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and are part of normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply reflect natural genetic variation. In some situations, however, a variant can change how a gene functions more significantly and may contribute to, or sometimes cause, a genetic condition.
Genetic variants
What if the gene does not work
Changes in the IGFBP6 gene can alter how well its protein folds, stays stable, is released from cells, or binds IGF2. The way variants in the IGFBP6 gene affect protein function often depends on the type of change: milder DNA changes may partly reduce binding or stability, while more severe loss-of-function variants (changes that greatly reduce or stop protein activity) can markedly lower protein levels or create a shortened protein that works poorly.
How variants are linked to conditions
At this point, IGFBP6 gene variants are not broadly confirmed as a cause of a specific inherited health condition, although research on possible IGFBP6 gene variants linked to conditions is still evolving. Anyone with a confirmed change in the IGFBP6 gene should use advice from their doctor or genetic counselor to interpret what it may mean for their own health.
A variant is not necessarily a diagnosis
Gene variants are a usual part of human biology and are common across the general population. Most have no direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the IGFBP6 gene. If testing has found a change in IGFBP6, a doctor or genetic counselor can help explain what it may mean in the context of your personal and family history.
Inheritance of IGFBP6 variants
There is not yet a broadly confirmed, disease specific Mendelian IGFBP6 gene inheritance pattern used in routine human genetics. Current understanding of IGFBP6 gene inheritance may evolve as research clarifies whether certain variants are linked to a defined condition. The IGFBP6 gene is located on chromosome 12, which is an autosome, so each person inherits one copy from each parent. This means any IGFBP6 variant, if clinically relevant, could be passed through either side of the family.
What does my IGFBP6 result mean for my family?
There isn't yet a broadly confirmed inheritance pattern tied to a specific condition for IGFBP6, though this understanding can change as research develops. If you have a specific IGFBP6 result and questions about what it could mean for your family, a doctor or genetic counselor can explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for IGFBP6 variants usually uses a blood or saliva sample to read the DNA sequence of the IGFBP6 gene, often through a multigene panel, exome, or genome test. Experts compare your result with a reference sequence and classify any variant using current medical evidence.
When should I consider getting a genetic test?
There is not yet a broadly established medical reason to order genetic testing just for the IGFBP6 gene. Decisions about testing are best made with a doctor or genetic counselor, based on your personal health history, family history, and the reason testing is being considered.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it explains depends on the condition and the kind of variant present. Over time, many factors, including lifestyle, environment, age, and medical history, affect how the body functions. In some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and is most useful when viewed together with other parts of care. In other situations, a genetic result can give a clear answer. For medication response, genetic results can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or responds to a drug, so the same treatment may work better for one person than for another. These differences are common and can influence both how well a medicine helps and how likely someone is to be more sensitive to side effects.
What is Pharmacogenetics?
Pharmacogenetics looks at how differences in a person’s genes can shape their response to medications. It examines connections between genes and drugs to help explain why the same treatment can work differently in different people. For many medicines, genes can affect how strongly a drug works or how the body handles it. This understanding can support treatment decisions that are both more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the IGFBP6 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about medicines, side effects, or treatment changes are best discussed with your doctor.
History
Researchers identified the IGFBP6 gene in the early 1990s while mapping the family of insulin like growth factor binding proteins. Initially understood only through visible traits, later recognized as tied to a specific gene, IGFBP6 became known for its especially strong binding to IGF II, a growth signal studied in development and cancer research. From these first observations, research expanded steadily. Scientists then traced where the gene is active in different tissues and explored how its activity changes in tumors and other conditions. Over time, descriptions became more precise, and IGFBP6 found its place as part of the broader history of growth factor research. It remains mainly a gene of scientific and clinical research interest rather than one widely known in public discussions.